$1.72
2.99% today
Nasdaq, Dec 02, 10:13 pm CET
ISIN
US23666P1012
Symbol
DARE

Dare Bioscience, Inc. Stock price

$1.67
-0.25 13.02% 1M
-1.36 44.88% 6M
-1.45 46.47% YTD
-1.63 49.39% 1Y
-9.73 85.35% 3Y
-15.73 90.40% 5Y
-393.13 99.58% 10Y
-820.33 99.80% 20Y
Nasdaq, Closing price Mon, Dec 01 2025
-0.17 9.24%
ISIN
US23666P1012
Symbol
DARE
Industry

Key metrics

Basic
Market capitalization
$23.9m
Enterprise Value
$25.9m
Net debt
$2.0m
Cash
$5.0m
Shares outstanding
9.0m
Valuation (TTM | estimate)
P/E
- | negative
P/S
- | 44.3
EV/Sales
- | 48.1
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-27.2%
Return on Equity
67.4%
ROCE
-
ROIC
-
Debt/Equity
-0.6
Financials (TTM | estimate)
Revenue
- | $538.3k
EBITDA
- | -
EBIT
- | $-19.6m
Net Income
- | $-14.3m
Free Cash Flow
$-11.9m
Growth (TTM | estimate)
Revenue
- | 5,283.0%
EBITDA
- | -
EBIT
- | 16.4%
Net Income
- | -252.6%
Free Cash Flow
-8.0%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -2,652.1%
Free Cash Flow
-
More
EPS
-
FCF per Share
$-1.3
Short interest
1.7%
Employees
22
Rev per Employee
$0.0
Show more

Is Dare Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,078 stocks worldwide.

Dare Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Dare Bioscience, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Dare Bioscience, Inc. forecast:

Buy
90%
Hold
10%

Financial data from Dare Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
0.09 0.09
97% 97%
100%
- Direct Costs -0.01 -0.01
200% 200%
-11%
0.10 0.10
-
111%
- Selling and Administrative Expenses 8.87 8.87
23% 23%
9,856%
- Research and Development Expense 13 13
34% 34%
14,633%
-1.44 -1.44
95% 95%
-1,600%
- Depreciation and Amortization 0.19 0.19
375% 375%
211%
EBIT (Operating Income) EBIT -1.63 -1.63
94% 94%
-1,812%
Net Profit -1.68 -1.68
94% 94%
-1,867%

In millions USD.

Don't miss a Thing! We will send you all news about Dare Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dare Bioscience, Inc. Stock News

Neutral
Seeking Alpha
10 days ago
Daré Bioscience, Inc. ( DARE ) Discusses DARE to PLAY Sildenafil Cream as a Treatment Option for Female Genital Arousal Concerns November 17, 2025 12:00 PM EST Company Participants Jennifer Kiang Sabrina Johnson - CEO, President, Principal Financial Officer, Secretary & Director Conference Call Participants Sheryl Kingsberg Jim Simon Presentation Jennifer Kiang All right. Good morning, everyone...
Neutral
Seeking Alpha
19 days ago
Daré Bioscience, Inc. ( DARE ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants MarDee Haring-Layton - Chief Accounting Officer Sabrina Johnson - CEO, President, Principal Financial Officer, Secretary & Director Conference Call Participants Catherine Novack - JonesTrading Institutional Services, LLC, Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC,...
Neutral
GlobeNewsWire
19 days ago
DARE to PLAY™ Sildenafil Cream on Track to Launch Before Year End via 503B Pathway, Paving the Way for Near-Term Product Revenue Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Continued Enrollment Multiple Grant-Funded Programs Advance, Including to Address HPV and Long-Acting as well as Non-Hormonal Contraception Four Commercially Available Solutions for Women Expected Over...
More Dare Bioscience, Inc. News

Company Profile

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Head office United States
CEO Sabrina Johnson
Employees 22
Founded 2015
Website www.darebioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today